Trial intelligence / Profile preview

Envarsus Dosing in de Novo Kidney Transplant Recipients

NCT03713645Phase 4Completed

Sponsor
Temple University
Start
Nov 2018
Primary completion
May 2021
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tacrolimus in kidney transplantation, sponsored by Temple University. Started Nov 2018; status: completed.

02

Drugs

tacrolimus
03

Conditions

kidney transplantation

Beyond the preview

Go deeper on NCT03713645.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03713645.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call